The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
AMA Update Tuesday, Congressional leaders released a health care package to accompany the FY 2025…
Practice Corner FAQ’s Q: Is there a maximum number for allergen tests? A: For an…
from CRD Associates Election Update Donald Trump won the presidency with 312 electoral votes, with…
12/01/24: Research Grant Cycle
Learn more
04/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 27, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Bruce A. Scott, MD is talking about physician payment on CBS News Detroit. Bruce A…
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to…
"Gratitude is the inward feeling of kindness received. Thankfulness is the natural impulse to express…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
“Peanut allergy affects approximately 1 million children in the U.S. and only 1 out of 5 of these children will outgrow their allergy. Because there is no cure, allergic individuals must strictly avoid exposure to prevent severe and potentially life-threatening…
The Food and Drug Administration (FDA) has approved ProAir Digihaler (albuterol sulfate) inhalation powder for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversable obstructive airway disease, and for prevention of exercise-induced bronchospasm (EIB)…
FDA has a drug shortage database which includes reasons for and updates on drug shortages. Today the database read, “Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen® and the authorized generic version, continues to experience manufacturing constraints. Currently, supplies will vary from…
The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr. FDA Commissioner Scott Gottlieb, M.D states that “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a…
There seem to be more and more medications available for allergy treatment that you can now purchase over the counter. The FDA has allowed some previously "prescription-only" drugs available directly to the consumer without a prescription which adds even more…
You have allergy symptoms, and want to find something to treat your symptoms without having to go to a doctor. The allergy aisle in the pharmacy or big box store is overwhelming. What do all these drugs do? Let's break…
Overview Allergy to penicillin and related antibiotics is the most commonly reported drug allergy in the United States. Approximately 85% of patients who describe themselves as “penicillin allergic” will have negative skin tests and can safely receive penicillin and related…
I never heard anything about gluten before 5 years ago, now you can’t swing a baguette without hearing about gluten. What gives? Gluten is a naturally-occurring protein present in several cereal grains. Wheat , Barley, and Rye are the principal…
Food allergies are a growing health concern with a significant increase in reported prevalence. Allergic reactions to food can produce life-threatening anaphylaxis. Peanut allergy in particular is a significant public health problem with no proven treatment nor a cure at the…
